GlassScriptPhysician profile
Robert M Malanuk
NPI 1740242304
$25,406.01
in general payments reported to CMS, 2019-2025
48 companies · $7,695 in 2025
The $7,695 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,785 · 2020: $561 · 2021: $1,071 · 2022: $1,751 · 2023: $5,103 · 2024: $7,441 · 2025: $7,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $6,947 · Consulting Fee: $900 · Education: $31.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,359.00 |
| Food and Beverage | $6,947.26 |
| Consulting Fee | $900.00 |
| Education | $31.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14,677.91 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $1,319.36 | 2019-2025 | |
| Boston Scientific Corporation | $1,258.20 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Watchman Flx |
| Amgen INC. | $896.27 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $755.76 | 2021-2025 | Cobalt Dr Mri Surescan, Symplicity G3, Micra |
| Pfizer INC. | $740.23 | 2019-2025 | |
| Inari Medical, INC. | $685.45 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $665.44 | 2019-2025 | Jot Dx, Navitor, Esprit |
| Astrazeneca Pharmaceuticals LP | $394.28 | 2019-2025 | Farxiga, Wainua, Andexxa |
| Sanofi-Aventis U.S. LLC | $328.26 | 2019-2024 | |
| Abiomed | $320.07 | 2022-2025 | |
| Novo Nordisk INC | $270.35 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Stryker Corporation | $264.36 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Alnylam Pharmaceuticals INC. | $236.33 | 2022-2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $234.94 | 2019-2024 | Xarelto |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $226.47 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $218.17 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.00 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.32 | 2022-2025 | Jardiance |
| Biotronik INC. | $128.77 | 2019-2025 | |
| Chiesi USA, INC. | $128.55 | 2020-2025 | Kengreal |
| Edwards Lifesciences Corporation | $101.39 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $99.52 | 2019-2022 | |
| Cardiovascular Systems INC. | $97.13 | 2019-2022 | |
| Bridgebio Pharma, INC. | $82.81 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $76.40 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $76.37 | 2019-2020 | |
| Astellas Pharma US INC | $66.00 | 2019-2020 | |
| Philips North America LLC | $61.98 | 2019-2024 | (Ck4) Mcot, (Bq9) Coronary Ivus |
| Medtronic Vascular, INC. | $60.87 | 2019-2020 | |
| Cordis US Corp. | $56.52 | 2024-2025 | Mynx Control Venous, Mynx Control, Mynx Venous Vcd |
| Regeneron Healthcare Solutions, INC. | $44.80 | 2022-2023 | Evkeeza, Praluent |
| Cardiva Medical, INC. | $42.70 | 2021-2025 | Optowire |
| Terumo Medical Corporation | $42.37 | 2020-2024 | Glidewire, Angio-Seal |
| Kestra Medical Technology Services, INC. | $42.35 | 2024 | Assure Wcd |
| Daiichi Sankyo INC. | $37.32 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $31.80 | 2023 | Opsumit |
| Esperion Therapeutics, INC. | $30.81 | 2023-2024 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $30.53 | 2023-2024 | Inpefa |
| Cardinal Health 200 LLC | $27.14 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.14 | 2019 | |
| Irhythm Technologies, INC. | $24.59 | 2020 | |
| Atricure, INC. | $19.24 | 2025 | Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System, Atricure Cryoice Cryoablation System (Cryo2) |
| Kiniksa Pharmaceuticals, LTD. | $18.40 | 2023 | Arcalyst |
| Portola Pharmaceuticals, LLC | $16.68 | 2019 | |
| Lantheus Medical Imaging, INC. | $13.66 | 2022 | |
| Corcept Therapeutics | $13.08 | 2024 | Korlym |
| B. Braun Interventional Systems INC. | $12.92 | 2023 | No Marketed Product Name |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Malanuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.